Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
1.65
0.28 (20.44%)
At close: Sep 05, 2025, 3:59 PM
1.63
-1.13%
After-hours: Sep 05, 2025, 07:50 PM EDT
Relmada Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 13. The median target predicts a decrease of -39.39% from the current stock price of 1.65.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 1 | 5 | 1 | 13 |
| Change | -39.39% | 203.03% | -39.39% | 687.88% |
Latest Analyst Insight Report
According to 3 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
| Rating | Sep 24 | Dec 24 |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 2 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 2 |
Financial Forecast this Year
Revenue This Year
2.46M
from 0
Increased by n/a%
Revenue Next Year
10M
from 2.46M
Increased by 306.7%
EPS This Year
-1.93
from -2.65
Increased by 27.2%
EPS Next Year
-0.99
from -1.93
Increased by 48.7%